Record-Breaking Human Whole Genome Sequencing Accelerates Genomic Diagnostics in Neonatal Intensive Care
Boston Children's Hospital
Current rapid genomic sequencing takes days, but critical NICU decisions often can't wait hours
Genomics
15,000 Women a Year with Breast Cancer Could Benefit from Whole Genome Sequencing, Say Researchers
University of Cambridge
Despite significant progress in recent years, it remains challenging to accurately identify the best treatments for individual patients and to predict cases with poorer prognosis
Blood-Based Multi-Cancer Detection Test Shows High Accuracy in Nature Medicine Study
Geneseeq
Geneseeq’s CanScan® test demonstrated 93 percent early-stage detection and a 98 percent specificity rate in a 3,700-person cohort
A New 'Link' to Triple-Negative Breast Cancer
Cold Spring Harbor Laboratory
New findings highlight the importance of non-coding RNAs in triple-negative breast cancer
Loss of Y Chromosome Leads to Poor Cancer Outcomes
Cedars-Sinai Medical Center
New findings could lead to improved immunotherapy options for male patients
Introducing a New Single-Cell Multiomics Workflow for Sequencing-Ready Libraries in Less than 10 Hours
Tecan, BioSkryb Genomics
The new workflow enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development, and precision medicine
The Missing Factor in Reliable Sequencing: Fragmentation Control
Today's Clinical Lab
Small changes in fragmentation lead to significant shifts in data quality. See the comparison
A Smoother Path From Sample To Sequencing
Annemarie Watson
With whole genome sequencing gaining traction in clinical labs, consistent sample prep is more important than ever
Optimizing Speed and Accuracy of NGS Solutions for Oncology Research
Konstantin Fiedler
Advanced sequencing solutions make high-precision NGS more accessible for labs of all sizes
GUARDIAN Study: Genomic Newborn Screening Will Transform the Rare Disease Landscape
Paul Kruszka, MD, MPH, FACMG
The GUARDIAN offers proof of principle that we can implement advanced genomic testing on a large scale